l-carnitine cancer risk Serum carnitine and risk: a Mendelian randomization study identifying pancreatic cancer as a modifiable metabolic target | Discover Oncology Safety, Tolerability and Symptom Outcomes
Description
This technical formula is designed to complement the nutritional profile in adults with an active lifestyle and high-performance athletes
doi: 10.4103/1817-1745.193363
Individuals at high risk for cardiovascular events, including secondary prevention candidates, will likely already be on or qualify for therapies known to reduce hs-CRP in addition to improving overall cardiovascular outcomes, such as statin or aspirin therapy
(1 dvka) 1 tableta
Para continuar, ingresa atu cuenta trace-id: fb4f1778-521e-4442-8fdc-2bfd71591ec7 Usamos cookies para mejorar tu experiencia en Mercado Libre
